Recreational Drugs Market Size

Recreational Drugs Market size was over USD 321.45 million in 2024 and is projected to reach USD 669 million by 2037, growing at around 5.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of recreational drugs is assessed at USD 336.37 million. The market is expanding due to increased demand for legal recreational drugs worldwide. On the other hand, taxes on recreational drugs benefit the economy by providing significant income. New work opportunities in retail are being created, which is transforming the employment landscape. According to recent research, the cannabis business in Canada employed 1,51,000 people and added USD 44 billion to the GDP between 2018 and 2021.

Consumers are seeking new ways of captivating recreational drugs in the form of inhalation or infusion. These processes leave a long-lasting impact on the consumer in comparison to edible ones. This creates opportunity for manufacturers to evolve their old selling patterns to meet the growing demand for recreational drugs.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of recreational drugs is assessed at USD 336.37 million.

The recreational drugs market size was over USD 321.45 million in 2024 and is projected to reach USD 669 million by 2037, growing at around 5.8% CAGR during the forecast period i.e., between 2025-2037. Meeting the increasing market pull for recreational drugs due to rise in population, acceptance, and exposure will drive the market growth.

North America industry is anticipated to account for largest revenue share of 39% by 2037, driven by rapid urbanization in the region.

The major players in the market include Manitoba Harvest, Tilray, Inc., Aos Products, Suyash Ayurveda, Isodiol International Inc., ENDOCA, North American Hemp & Grain Co, India hemp and co, Canopy Growth Corporation, Cannablithe

Recreational Drugs Market Size